This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rahmouni, K. Articles by Mark, A. L. Search for Related Content PubMed PubMed Citation Articles by Rahmouni, K. Articles by Mark, A. L. Related Collections Obesity Animal models of human disease Other hypertension Hypertension - basic studies Autonomic, reflex, and neurohumoral control of circulation Receptor pharmacology

(Hypertension. 2002;39:486.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Selective Resistance to Central Neural Administration of Leptin in Agouti Obese Mice

Kamal Rahmouni; William G. Haynes; Donald A. Morgan; Allyn L. Mark

From the Hypertension Genetics Specialized Center of Research, Cardiovascular Center, and Department of Internal Medicine, University of Iowa, and the Veterans Administration Medical Center, Iowa City, Iowa.

Correspondence to Allyn L. Mark, MD, 218 CMAB, University of Iowa, Iowa City, IA 52242-1101. E-mail allyn-mark{at}uiowa.edu

Abstract— We recently demonstrated that in a rodent model of obesity (agouti yellow mice), there is a selective leptin resistance with preservation of the sympathetic actions despite loss of appetite and weight-reducing actions of systemic leptin. Here, we examined whether selective leptin resistance exists in agouti mice during central neural administration of leptin. In agouti obese mice and lean controls, we tested the effects of single intracerebroventricular (ICV) injection of leptin or vehicle on food intake and body weight in the conscious state and on renal sympathetic nerve activity during anesthesia. Agouti obese mice had higher (P<0.0001) mean arterial pressure (100±2 mm Hg) than lean controls (90±2 mm Hg). In lean controls (n=9 to 10), ICV leptin caused a dose-dependent decrease in body weight (P<0.001) and food intake (P<0.001). For example, ICV leptin (3 µg) decreased food intake and body weight, respectively, by 3.3±0.3 g (P<0.001) and 2.6±0.3 g (P<0.001) in lean mice. However, in agouti obese mice (n=9 to 10), ICV leptin did not significantly decrease food intake or body weight. ICV leptin caused in RSNA a significant and dose-dependent increase in renal sympathetic nerve activity that was of the same magnitude in the lean and agouti obese mice. The rise in renal sympathetic nerve activity induced by ICV leptin (3 µg) was 274±67% (P<0.001) in lean controls and 275±46% (P<0.001) in the agouti obese mice. In summary, this study indicates that selective leptin resistance in agouti obese mice occurs with central neural administration of leptin, suggesting that selective leptin resistance in this model is not due to a defect in leptin transport across the blood brain barrier. It seems to result instead from alterations in the central neural pathways mediating effects of leptin.

Key Words: obesity • hypertension, obesity • sympathetic nervous system • mice

This article has been cited by other articles:

				D. A. Morgan, D. R. Thedens, R. Weiss, and K. Rahmouni Mechanisms mediating renal sympathetic activation to leptin in obesity Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1730 - R1736. [Abstract] [Full Text] [PDF]

				E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF]

				J. D. Knudson, U. D. Dincer, G. M. Dick, H. Shibata, R. Akahane, M. Saito, and J. D. Tune Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1038 - H1046. [Abstract] [Full Text] [PDF]

				K. Rahmouni, D. A. Morgan, G. M. Morgan, A. L. Mark, and W. G. Haynes Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension Diabetes, July 1, 2005; 54(7): 2012 - 2018. [Abstract] [Full Text] [PDF]

				K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark Obesity-Associated Hypertension: New Insights Into Mechanisms Hypertension, January 1, 2005; 45(1): 9 - 14. [Abstract] [Full Text] [PDF]

				A. A. da Silva, J. J. Kuo, and J. E. Hall Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin Hypertension, June 1, 2004; 43(6): 1312 - 1317. [Abstract] [Full Text] [PDF]

				K. Rahmouni and W. G. Haynes Leptin and the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244. [Abstract] [Full Text]

				B. E. Levin, A. A. Dunn-Meynell, and W. A. Banks Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R143 - R150. [Abstract] [Full Text]

				R. Wolk, A. S.M. Shamsuzzaman, and V. K. Somers Obesity, Sleep Apnea, and Hypertension Hypertension, December 1, 2003; 42(6): 1067 - 1074. [Abstract] [Full Text] [PDF]

				A. J. Marsh, M. A.P. Fontes, S. Killinger, D. B. Pawlak, J. W. Polson, and R. A.L. Dampney Cardiovascular Responses Evoked by Leptin Acting on Neurons in the Ventromedial and Dorsomedial Hypothalamus Hypertension, October 1, 2003; 42(4): 488 - 493. [Abstract] [Full Text] [PDF]

				K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin J. Neurosci., July 9, 2003; 23(14): 5998 - 6004. [Abstract] [Full Text] [PDF]

				K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark Intracellular Mechanisms Involved in Leptin Regulation of Sympathetic Outflow Hypertension, March 1, 2003; 41(3): 763 - 767. [Abstract] [Full Text] [PDF]